For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG) index experience faster cognitive decline.

Nonpharmacologic treatments, such as cognitive behavioral therapy, help reduce sleep disorders in patients with multiple sclerosis.

Compared to nonmilvet samples, military and veteran participants exhibited lower proportions of diagnosis loss after cognitive processing therapy.

Guidance is provided for the pediatrician regarding the genetic evaluation of developmental delay/intellectual disability.

Noninvasive brain stimulation techniques, including transcranial direct current stimulation, are effective nonpharmacologic treatments for insomnia.

Intermittent-fasting strategies yield small reductions in body weight compared with an ad libitum diet, according to a study.

Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study.

Depending on the follow-up time, depression/dysthymia may be predicted by different factors, including nationality and any past anxiety disorder.